ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "AMT-130 and the 75% Slowdown: What Just Changed for Huntington’s Disease—and What Hasn’t"
Episode Synopsis
We Have A Voice Radio dives into the AMT-130 news for Huntington’s—what this one-time, brain-delivered gene therapy is, what the reported “75% slowdown” really means, what’s next for approval, and the hard truths on access and cost.
More episodes of the podcast WeHaveAVoice
The Blue Within
23/08/2025
Huntington's Isn't Rare...It's Ignored
11/08/2025
The House That Doesn't Sleep
23/07/2025
The Kids Who Carry Too Much
25/06/2025
44% of Men Die Prematurely
17/06/2025
Rare Disease Day
13/02/2024
In God we trust